AFS Logistics and TD Cowen announce the third quarter (Q3) 2025 release of the TD Cowen/AFS Freight Index, a snapshot with ...

TD Cowen has raised its price target for Strategy’s stock from $590 to $680 per share, citing the company’s deepening role as ...

Andrew Charles, TD Cowen analyst, joins CNBC's 'Squawk on the Street' to discuss what potential tariffs on Brazil could mean ...

Craig Hutchinson, TD Cowen base metals equity research analyst, joins 'Squawk Box' to discuss which stocks can benefit from ...

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the 13 Best Healthcare Stocks to Buy Under $10. On May 1, analyst Ritu Baral from TD Cowen maintained a Buy rating on Amicus Therapeutics, Inc.

Enphase Energy falls following President Trump's executive order to scrap clean electricity tax credits faster than expected ...

The investment banking arm of TD Bank believes that the market cap of JPMorgan will soar to $1 trillion as it leverages ...

The chip maker sells the basic building-block chips that go into products in nearly every sector of the economy, from autos ...

Pricing expectations stalled in second-quarter 2025 and remain below our rail shipper survey’s long-term average. Business ...

TD Cowen is a New York-based investment bank and a division of TD Securities, with 27 offices globally. Founded in 1918, it’s led by their CEO Tim Wiggan.

TD Cowen analyst Gregory Williams maintained a Hold rating on AT&T on July 7 and set a price target of $30.00. The company’s shares closed today at $26.97. Take advantage of TipRanks Premium at 50% ...

Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in sales by 2035, analysts at TD ...